Huilin Cheng

Are we mis-estimating chemotherapy-induced peripheral neuropathy? Analysis of assessment methodologies from a prospective, multinational, longitudinal cohort study of patients receiving neurotoxic chemotherapy

Alex Molassiotis, Huilin Cheng, Violeta López et al. · BMC Cancer · 2019 · 215 citations · Full text

Medicine, Oncology, Pharmacology +17

Risk factors for chemotherapy‐induced peripheral neuropathy in patients receiving taxane‐ and platinum‐based chemotherapy

Alex Molassiotis, Huilin Cheng, Kwun To Leung et al. · Brain and Behavior · 2019 · 121 citations · Full text

Medicine, Neurology, Oncology +16

A Randomized Assessor-Blinded Wait-List-Controlled Trial to Assess the Effectiveness of Acupuncture in the Management of Chemotherapy-Induced Peripheral Neuropathy

Alex Molassiotis, Lorna Kwai Ping Suen, Huilin Cheng et al. · Integrative Cancer Therapies · 2019 · 109 citations · Full text

Medicine, Oncology, Pharmacotherapy +15

Social support and quality of life among Chinese breast cancer survivors: Findings from a mixed methods study

Huilin Cheng, Janet W. H. Sit, Carmen W.H. Chan et al. · European Journal of Oncology Nursing · 2013 · 81 citations

Social Sciences, Oncology, Social Psychology +15

Psychometric testing of the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group—Neurotoxicity (FACT/GOG-Ntx) subscale in a longitudinal study of cancer patients treated with chemotherapy

Huilin Cheng, Violeta López, Simon Ching Lam et al. · Health and Quality of Life Outcomes · 2020 · 62 citations · Full text

Medicine, Oncology, Cancer Drug Toxicity Management +15